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ABSTRACT  Cytoplasmic  extracts  of  meiotically  mature  mouse  oocytes  were  injected  into 
immature Xenopus laevis oocytes, which underwent germinal vesicle  breakdown within 2 h. 
Germinal  vesicle  breakdown  was  not  inhibited  by  incubaton  of  the  Xenopus  oocytes  in 
cycloheximide  (20  ug/ml).  Identically  prepared  extracts  of  meiotically  immature  mouse 
oocytes,  arrested at the germinal vesicle  stage by dibutyryl  cyclic AMP (100 tzg/ml),  did  not 
induce  germinal  vesicle  breakdown  in  Xenopus oocytes.  The  results  show that  maturation- 
promoting factor activity appears during the course of oocyte maturation in the mouse. 
Oocytes arrest their meiotic progression during late 02 phase 
of the first meiotic division. It is in this arrested stage that 
oocytes grow  in  preparation  for fertilization and  embryo- 
genesis. Fully grown oocytes reinitiate meiosis in response to 
a hormonal signal  at or near the time of ovulation. In am- 
phibians, pituitary gonadotropin triggers the production of a 
maturation-inducing substance (presumably progesterone) by 
follicle  cells encasing the oocyte. In turn, progesterone acts 
upon the surface of the oocyte to initiate meiotic maturation, 
which  involves dissolution  of the  nuclear membrane (ger- 
minal vesicle breakdown [GVBD]t), condensation of the in- 
terphase chromatin, spindle formation and completion of the 
first meiotic division, and arrest at metaphase of the second 
meiotic division (13, 20). 
The action of progesterone in inducing GVBD is mediated 
by a cytoplasmic maturation-promoting factor (MPF). Cyto- 
plasm  from  mature  frog  oocytes,  injected  into  immature 
germinal-vesicle stage oocytes, will induce maturation in the 
absence  of progesterone  (15).  MPF  from Xenopus  laevis 
oocytes has been purified >20-fold and has been characterized 
as a protein (or proteins) with a molecular weight of- 100,000 
(28). 
MPF  appears  to  be  ubiquitous.  MPF  activity has  been 
demonstrated in the amphibians Rana pipiens (15), X. laevis 
(19),  and Ambystoma  mexicanum  (17),  and in the starfish 
Asterina pectinifera  (6). MPF activity has also been demon- 
strated in amphibian blastomeres undergoing mitosis (15, 26), 
Abbrevialions used in this paper." FM I, flushing medium I; GVBD, 
germinal vesicle breakdown; MPF, maturation-promoting factor. 
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in  HeLa cells  and Chinese hamster ovary cells  arrested in 
metaphase of mitosis (16,  23),  and in yeast (27).  Insofar as 
MPF controls the transition  from G2  to M  phase in  both 
meiosis and mitosis, Gerhart et al. (4) propose that the acro- 
nym MPF refers to "M-phase promoting factor." 
MPF also appears to lack species specificity, which suggests 
that it has been highly conserved in evolution. MPF from 
each  of three  different species  of starfish  was  effective in 
inducing maturation after injection into oocytes of the other 
two species  (7).  Similarly, MPF from R. pipiens,  X.  laevis, 
and  A.  mexicanum  induced  maturation  in  one  another's 
oocytes (17).  MPF from mammalian  mitotic cells  induced 
meiotic maturation in X.  laevis (16,  23) and A. pectinifera 
oocytes (8),  and  MPF  from  Bufo  bufo japonicus  oocytes 
induced  meiotic maturation  in  starfish  and  sea cucumber 
oocytes (8). 
Recently, Kishimoto et al. (9) demonstrated maturation of 
starfish oocytes injected with cytoplasm from maturing mouse 
oocytes. It was the purpose of the study reported here to test 
for the appearance of MPF during mouse oocyte maturation 
by using X. laevis oocytes as the test system. 
MATERIALS  AND  METHODS 
For the collection  of mature oocytes,  8-10-wk-old CFI  female mice (Charles 
River Breeding Laboratories, Inc,, Wilmington, MA) were induced to supero- 
vulate by intraperitoneal injections of 5 IU of pregnant mare's serum gonado- 
tropin (Teikoku Zoki Co., Tokyo, Japan) and human chorionic gonadotropin 
(Ayerst Laboratories,  New York,  NY) 48-52  h  apart.  For the collection  of 
immature oocytes, nonsuperovulated  4-5-wk-old females were used. Mice were 
kept in the light for 14 h and in the dark for 10 h. 
1637 14 h after injection  of human chorionic gonadotropin,  oviducts were dis- 
sected, swollen ampullae were nicked, and cumulus masses were expelled into 
modified  Hanks'  balanced  salt  solution  (flushing  medium  [  [FM  I]  [22]). 
Hyaluronidase (Type IV, Sigma Chemical Co., St. Louis, MO) was added to a 
final concentration  of 0.05%. Cumulus masses were incubated  at room tem- 
perature  until mature oocytes were freed (- 15 min). Oocytes were washed in 
FM ! several times to remove cumulus cells. 
Immature (germinal-vesicle stage) oocytes were freed from their follicles by 
teasing  apart  ovaries  in  FM  I.  Cumulus cells were  removed  by  repeated 
pipetting, and oocytes were washed in FM I several times. Oocytes were arrested 
at the germinal vesicle stage by the addition of 100 ug/ml dibutyryl cyclic AMP 
(Sigma Chemical Co.) to the FM 1 (3) from the moment the oocytes were freed 
until the final wash (-2 h). 
Zonae pellucidae were digested by the incubation of oocytes in 0.5% pronase 
(Type B, Calibochem-Behring Corp., La Jolla, CA) at 37"C for 3 min. Oocytes 
were quickly washed in several changes of FM I. Just before extraction, oocytes 
were washed several times in calcium- and magnesium-free FM  I and trans- 
ferred to miniature  centrifuge tubes constructed  by flaming closed one end of 
a  capillary  tube  (Kimax-51,  0.8-ram  i.d.,  Kdmble Products,  Toledo,  OH). 
Oocytes were washed through two changes of ice-cold extraction  buffer  (80 
mM sodium 13-glycerophosphate, 20 mM sodium EGTA,  15 mM MgCI2, pH 
7.3, plus 0.1  mM  8-thiolated  ATP,  1 mM dithiothreitol,  and the  following 
protease inhibitors: 0. I t,g/ml pepstatin,  5 uM phenylmethylsulfonyl fluoride, 
0.25 ug/ml leupeptin, 0.25 ug/ml aprotinin,  10 uM benzamidine  HCI [28] by 
low-speed centrifugation.  After removal of all but ~ 1 ul of extraction  buffer, 
oocytes  were  disrupted  by  repeated  pipetting  through  a  mouth-controlled 
pipette with an inner diameter  ~~/3 that of the  oocyte. The homogenate  was 
centrifuged at  10,000 g for  10 min at 4"C, and the supernatant  (extract) was 
used to assay MPF activity (Fig. 1  ). 
Adult X. laevis were obtained  from Xenopus I (Ann Arbor,  MI). Females 
were injected via the dorsal lymph sac with 20-50 IU of  pregnant mare's serum 
gonadotropin  3 d before the surgical removal of ovaries. Stage 6 oocytes were 
dissected manually  for use in the injection assay of MPF. Cycloheximide was 
obtained from the Sigma Chemical Co. 
Mouse  oocyle  extracts  were  injected  in  50-hi aliquots  into  the  animal 
hemispheres of Xenopus oocyles. The total number of 50-hi aliquots recovered 
from the  centrifuge  tube  was used to estimate  the total  volume  of extract. 
Xenopus oocytes were incubated at room temperature  after injection. 2 h after 
injection, GVBD was assessed by the appearance of a characteristic white spot 
in  the  pigmented  animal  hemisphere.  Assessment was confirmed  by  fixing 
oocytes for 10 min in  10% trichloroacetic acid and dissecting them to observe 
the presence or absence of a germinal vesicle. 
RESULTS 
Extracts from mature ovulated mouse oocytes induced GVBD 
in immature X. laevis  oocytes within 2 h after injection (Table 
FIGURE  1  Mature  oocytes before (/eft) and after  (right)  extraction. 
Whole  oocytes were disrupted  and  centrifuged  in capillary tubes. 
A common straight pin is included to demonstrate scale. Bar, 1 mm. 
x  11.4. 
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I). Buffer-injected control Xenopus oocytes gave no response. 
The MPF activity was estimated by calculation of the number 
of mouse  oocytes  in  the  volume  of extract  injected.  The 
minimum  number  of mouse  oocytes  that  gave a  positive 
response  in  the  injected  recipient  oocytes was  23.  Mature 
oocytes extracted by freezing and thawing were completely 
ineffective in inducing maturation. Two samples of Xenopus 
oocytes incubated  in  20  ~tg/ml  cycloheximide and  injected 
with  extracts  from  mature  mouse  oocytes also  underwent 
GVBD (Table II). Treatment of Xenopus oocytes with this 
concentration  of  cycloheximide  inhibits  >95%  of  3sS- 
[methionine] incorporation into protein (Gerhart, J., personal 
communication). 
In  contrast  to  the  mature  ovulated  oocytes,  extracts  of 
immature germinal-vesicle stage ovarian oocytes arrested by 
incubation in dibutyryl cyclic AMP did not induce GVBD in 
Xenopus oocytes even though the number of mouse oocytes 
injected  per  recipient  oocyte  (34-64)  was  well  above  the 
number  of mature  oocytes demonstrated  to  cause  GVBD 
(Table  III). Xenopus oocytes co-injected with  extract from 
immature mouse oocytes and with active Xenopus MPF did 
undergo GVBD (data not shown). 
DISCUSSION 
The results reported allow the mouse oocyte to be included 
among the known meiotic and mitotic cell types in which the 
transition from G2 to M  phase is regulated by a cytoplasmic 
factor. The appearance of a  cytoplasmic MPF in  maturing 
mouse oocytes was first suggested by Balakier and CzoIowska 
(2),  who  observed  that  anucleate  fragments  of immature 
mouse oocytes, when  fused to interphase blastomeres from 
two-celled mouse embryos, induced premature dissolution of 
the nuclear membrane and premature chromatin condensa- 
tion  in  the  blastomeres when  the  nucleate  sister  fragment 
underwent GVBD. 
The precocious induction of GVBD (<2 h) compared with 
the time of progesterone-induced maturation (>3 h) supports 
the  conclusion  that  the  active agent in  extracts of mature 
mouse oocytes is MPF. According to the evolving model of 
progesterone control  of amphibian  oocyte maturation  (12, 
14), it is the phosphorylation of preexisting MPF that triggers 
GVBD. Progesterone, the maturation-inducing substance in 
amphibians, is proposed to release calcium ions from the cell 
surface that activate a cytoplasmic phosphodiesterase, which 
in turn decreases the concentration of cyclic AMP. A lowered 
cyclic AMP  concentration  leads  to  inactivation  of protein 
kinase, resulting in dephosphorylation of a  hypothetical ini- 
tiator protein, changing it from an inactive to an active state. 
The initiator protein is proposed to be a  cyclic AMP-inde- 
pendent protein kinase responsible for the phosphorylation 
and activation of inactive MPF. MPF also may be a protein 
kinase capable of phosphorylating itself,  thus explaining its 
observed autocatalytic behavior on serial transfer (15).  The 
distal position of MPF in this elaborate protein phosphoryla- 
tion cascade explains the more rapid response of oocytes to 
MPF injection compared with the time of oocyte response to 
progesterone treatment. 
The induction of GVBD in the presence of cycloheximide, 
an inhibitor of protein synthesis, can be considered definitive 
evidence for MPF activity in mature mouse oocyte extract. 
Progesterone-treated Xenopus oocytes do not mature in cyclo- 
heximide, but become increasingly resistant to the inhibitor 
as the maturation process progresses (25). Cycloheximide does TABLE  I 
Injection of Extract from Mature Mouse Oocytes into Immature Xenopus Oocytes 
Experiment 
No. 
No. of Xenopus 
No. of mouse  No. of mouse  No. of Xenopus  oocytes  Xenopus  oo- 
oocytes ex-  Total volume  Volume of ex-  oocytes per in-  oocytes receiv-  undergoing  cytes undergo- 
tracted  of extract  tract injected  jection  ing injection  GVBD  ing GVBD 
pl  nl 
600  2.6  100  23  9  7  78 
150  35  6  2  33 
200  46  4  4  100 
450  1.5  50  16  8  0  0 
100  32  5  4  80 
567  0.6  25  24  3  3  100 
50  47  4  4  100 
100  95  3  3  100 
TABLE  II 
Injection of Extract from Mature Mouse Oocytes into Cycloheximide-treated  Immature Xenopus Oocytes 
No. of Xenopus 
No. of mouse  No. of mouse  No. of Xenopus  oocytes  Xenopus  oo- 
Experiment  oocytes ex-  Total volume of  Volume of ex-  oocytes per in-  oocytes receiv-  undergoing  cytes undergo- 
No.  tracted  extract  tract injected  jection  ing injection  GVBD  ing GVBD 
#1  nl  % 
1  450  1.50  100  32  3  1  33 
2  285  0.65  50  22  5  5  100 
100  44  4  4  100 
Xenopus oocytes were incubated for 1 h in 20 pg/ml cycloheximide before injection and incubated continuously in 20 pg/ml cycloheximide after injection. 
TABLE III 
Injection of Extract from Immature Mouse Oocytes into Immature Xenopus Oocytes 
No, of Xenopus 
No. of mouse  No. of mouse  No. of Xenopus  oocytes  Xenopus  oo- 
Experiment  oocytes ex-  Total volume of  Volume of ex-  oocytes per in-  oocytes receiv-  undergoing  cytes undergo- 
No.  tracted  extract  tract injected  jection  ing injection  GVBD  ing GVBD 
pl  nl  ® 
1  385  0.60  100  64  5  0  0 
2  309  0.90  100  34  6  0  0 
Maturation of mouse oocytes was arrested by the addition of 100/~g/ml dibutyryl cyclic AMP to the collection medium. 
not prevent maturation of oocytes injected with MPF (25, 28) 
and does not prevent the appearance of high concentrations 
of MPF when oocytes are injected with low concentrations of 
MPF (4). These data suggest that MPF is present in the oocyte 
before GVBD and is activated post-translationally, most likely 
by phosphorylation. The hypothesis that the phosphorylation 
cascade depends  upon the  synthesis of an initiator protein 
nominates it as a target of cycloheximide action. Since MPF 
acts "downstream" from the initiator protein, injected MPF 
would not be sensitive to the inhibition of protein synthesis. 
Other substances capable of inducing GVBD upon injection, 
such as the R and I proteins of cyclic AMP metabolism ( 11 ), 
are  sensitive  to  cycloheximide  owing  to  their  "upstream" 
position in this hypothetical cascade. 
Consistent with the cascade model for progesterone action, 
the maintenance of a high cyclic AMP concentration would 
prevent MPF activation. The failure of an extract ofdibutyryl 
cyclic AMP-arrested mouse oocytes to induce GVBD after 
injection into Xenopus oocytes is therefore predicted. Dibu- 
tyryl  cyclic  AMP-arrested  mouse  oocytes,  however,  do 
undergo initial chromosome condensation and extensive con- 
volution of the germinal vesicle membrane (24), two changes 
associated with incipient GVBD. These initial maturational 
events, therefore, do not appear to be regulated by MPF. 
Sunkara et al.  (23)  calculated that a  minimum of 1,000 
mitotic HeLa cells (with  a  mean diameter of 17  vm) was 
capable of causing 100% maturation after injection into Xen- 
opus oocytes. With a diameter of 72 pm (10), mouse oocytes 
have 75  times the volume of a  HeLa cell.  Accordingly,  13 
mature mouse oocytes should be the minimum number ca- 
pable of causing a response in Xenopus oocytes, assuming an 
equivalent MPF concentration in both HeLa cells and mouse 
oocytes.  This  value  is close to  the  estimated value in  this 
study. 
The question of  the relationship of MPF to the development 
of meiotic competence in mouse oocytes is intriguing. Soren- 
sen  and  Wassarman  (21)  observed  that  small  oocytes  re- 
covered  from  mice  younger than  15  d  post  partum  were 
incompetent to mature in culture. Balakier (1) reported that 
incompetent young oocytes that were fused with  maturing 
oocytes or  four-cell  blastomeres  were  arrested  in  meiosis, 
underwent GVBD, and progressed to metaphase of the first 
meiotic division. The injection of MPF into small Xenopus 
oocytes incapable  of responding  to  progesterone treatment 
SORENSEN El- AL.  Maturation-promoting Factor in Mouse Oocytes  1639 induced GVBD (5, 18). Our preliminary attempts to microin- 
ject either concentrated Xenopus MPF (28) or freshly prepared 
extract  of mature  mouse  oocytes into  incompetent  mouse 
oocytes have failed to induce GVBD (Sorensen,  R. A., and 
R. A. Pedersen, unpublished results). Insofar as the microin- 
jected  volume is  considerably less than  that  introduced  by 
fusion of a whole oocyte, either incompetent mouse oocytes 
are completely deficient in MPF, which can only be provided 
by  the  massive  transfusion  of cytoplasm  afforded  by  cell 
fusion, or they do not possess sufficient MPF to be activated 
by the injection of a small volume of active MPF. 
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